Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Depreciation & Amortization (CF) (2016 - 2025)

Veracyte (VCYT) has disclosed Depreciation & Amortization (CF) for 14 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 15.27% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, down 8.71% year-over-year, with the annual reading at $21.4 million for FY2025, 8.71% down from the prior year.
  • Depreciation & Amortization (CF) hit $5.3 million in Q4 2025 for Veracyte, up from $5.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.3 million in Q3 2023 to a low of $2.6 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $5.9 million across 5 years, with a median of $6.2 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 216.25% in 2021 and later fell 19.73% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $6.4 million in 2021, then increased by 2.37% to $6.6 million in 2022, then decreased by 3.36% to $6.3 million in 2023, then decreased by 1.31% to $6.3 million in 2024, then fell by 15.27% to $5.3 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for VCYT at $5.3 million in Q4 2025, $5.3 million in Q3 2025, and $5.5 million in Q2 2025.